Medical mishaps

November 26, 2014 | By Bjorn Rembacken

Mistakes happen. This is the reason why my Volvo has large rubber bumpers and why pencils have rubbers. Indeed, I, amongst many others, may have been born for this very reason. It has long been recognised that mistakes also happen when providing health care. Of course, there are lots of reasons that such mistakes occur, including sleep deprivation, being rushed, having illegible hand writing, deli

Journal Watch

Can't get to the caecum! Now what? Colon capsule endoscopy versus CT colonography

November 18, 2014 | By Ahmed Gabr

Endoscopists usually resort to performing CT colonography (CTC) in cases of incomplete colonoscopy. Colon capsule endoscopy (CCE) is a new technique that has potential advantages over CTC.

Journal Watch

SVR: 24, 12 or maybe 4?

November 13, 2014 | By Sanju Mathew

How long does it take to determine whether the treatment for chronic hepatitis C (HCV) has been successful? In the past, patients had to wait 24 weeks to assess whether they had achieved a sustained virological response (SVR24). A recent article by Yoshida et al. looks at the data to support using a shortened SVR time point with sofosbuvir, in the new wave of HCV treatments.

Journal Watch

Treatment failure in patients with chronic hepatitis E: are we a step forward?

November 11, 2014 | By Santoshkumar S Salunke

Ribavirin (RBV) is used for the treatment of patients with chronic hepatitis E, but RBV is associated with treatment failure and associated mortality. A new in vitro study identifies a virulence mutation in the hepatitis E virus (HEV) genome that may explain why treatment failures occur.

Journal Watch

Finding the right level: infliximab levels, antibodies to infliximab and disease activity in Crohn's disease

November 06, 2014 | By Philip J Smith

With the widespread use of biologics such as Infliximab (IFX) for the treatment of IBD, research has focused on why some individuals respond well to their use, whilst others lose response over time or don't respond at all. Attention has focused on the role of antibodies to IFX (ATI) and whether they are responsible, at least in part, for this phenomenon, and whether monitoring and measuring ATI is useful for frontline clinicians treating patients.

Online courses

Feeding Difficulties

ESPGHAN's new online course offers a comprehensive review of the best practices in diagnosis and treatment.
Take course

Web Editors

Meet the editorial team

Recruited from across Europe, our dedicated web editors are responsible for the content of UEG E-learning.
Find out who they are

Latest Content

UEG Week Live Endoscopies

Amongst the highlights of UEG Week 2014 were the live endoscopies, professionally recorded and now available on UEG Education.
Buy now

Back to Top